Newest Coronavirus Information
THURSDAY, Jan. 27, 2022 (HealthDay Information)
COVID-19 is altering medication in one more method: A brand new examine finds that sufferers with COVID-related lung injury now account for practically one in 10 lung transplants in the US.
The researchers analyzed information on greater than 3,000 lung transplants nationwide between Aug. 1, 2020, and Sept. 30, 2021. They discovered that 7% of them had been carried out to deal with extreme, irreversible lung injury attributable to COVID-19.
The common age of the 214 COVID lung transplant sufferers was 52, and the speed of three-month survival was practically 96%.
The findings confirmed that 140 sufferers had COVID-19 acute respiratory distress syndrome, and 74 sufferers had COVID-19 pulmonary fibrosis.
“Acute respiratory distress syndrome entails an acute irritation of the lungs, leading to decreased means for the lungs to oxygenate and ventilate,” stated examine co-author Dr. Amy Roach. She’s a normal surgical procedure resident and analysis fellow at Smidt Heart Institute of Cedars-Sinai Medical Middle in Los Angeles.
“In some sufferers this progresses to COVID-19 pulmonary fibrosis, which causes scarring within the lung and is mostly irreversible,” Roach stated in a medical heart information launch.
Greater than half of the 214 sufferers required ventilators or extracorporeal membrane oxygenation (ECMO) earlier than their transplant, in accordance with the examine. The outcomes had been revealed Jan. 26 within the New England Journal of Medication.
Research co-author Dr. Joanna Chikwe stated, “Our expertise treating COVID-19 has proven us that ECMO can be utilized in rigorously chosen sufferers, both as a bridge to lung transplantation, or to permit a affected person’s personal lungs to heal.” Chikwe is chair of the heart institute’s division of cardiac surgical procedure.
“Most of those COVID-19 sufferers would have been thought-about too in poor health to transplant a couple of years in the past, and the stunning discovering of our analysis was how effectively they did after lung transplantation,” she added.
ECMO entails pumping a affected person’s blood from the physique and thru a synthetic lung earlier than being returned to the physique.
Between July 2020 and June 30, 2021, Cedars-Sinai offered greater than 30,000 hours of ECMO care to sufferers. Of these, 21,000 hours had been for sufferers with extreme lung illness because of COVID-19.
For extra on how COVID-19 impacts the lungs, go to the U.S. National Heart, Lung, and Blood Institute.
SOURCE: Cedars-Sinai Medical Middle, information launch, Jan. 26, 2022
Copyright © 2021 HealthDay. All rights reserved.